The battery-powered device is the first to detect Mycobacterium tuberculosis in saliva in addition to blood and sputum.

Early Detection and sustained treatment are key factors in ending tuberculosis. Pulmonary Medicine Specialist Helarose M.

Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical ...

An outbreak of tuberculosis within Kansas City in the United States has been ongoing since Jan. 2024 and has highlighted new ...

Previous TB treatment (left image) involved handfuls of daily pills ... Cattamanchi is also UC Irvine’s division chief of pulmonary diseases and critical care medicine. Other forms of testing need ...

KIMS Hospitals leads India’s largest AI-driven TB study, analyzing 16,675 chest X-rays and proving AI’s high accuracy in ...

"The completion of the first cohort in this study is an important milestone as we progress a novel long-acting injectable and targeted treatment option for patients with pulmonary TB," said Dr ...

Learn about the primary ways tuberculosis spreads through airborne transmission, high-risk settings, and effective prevention ...

The target of ending the global TB epidemic by 2035 is achievable, Cimas Health Group doctor Philip Manema believes, if there is commitment to investing in the pillars of the global strategy for ...

Berhampur: The state govt has rolled out BPaLM, a shorter duration new treatment regimen for multi-drug resistant ...

Similarly, the treatment time for drug-susceptible TB has nearly halved ... Cattamanchi is also UC Irvine's division chief of pulmonary diseases and critical care medicine. Other forms of testing ...